Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Carphenazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 known ✓ | P14416 | 7/20 | 0.81 |
| ▸ | HTR2A known ✓ | P28223 | 7/20 | 0.81 |
| ▸ | HTR2C known ✓ | P28335 | 5/20 | 0.67 |
| ▸ | HRH1 | P35367 | 10/20 | 0.81 |
| ▸ | HTR1A | P08908 | 7/20 | 0.81 |
| ▸ | ADRA2C | P18825 | 7/20 | 0.81 |
| ▸ | ADRA1A | P35348 | 7/20 | 0.81 |
| ▸ | DRD3 | P35462 | 7/20 | 0.81 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.81 |
| ▸ | ADRA2B | P18089 | 6/20 | 0.81 |
| ▸ | HTR2B | P41595 | 6/20 | 0.81 |
| ▸ | SLC6A2 | P23975 | 6/20 | 0.81 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.81 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.81 |
| ▸ | ADRA2A | P08913 | 5/20 | 0.81 |
| ▸ | DRD1 | P21728 | 4/20 | 0.81 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.81 |
| ▸ | MLNR | O43193 | 1/20 | 0.81 |
| ▸ | ESR1 | P03372 | 1/20 | 0.81 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carphenazine SCHEMBL1458434 | 1.00 | HRH1 (0.81) | HRH1HTR1ADRD2ADRA2CHTR2A | |
| Carphenazine SCHEMBL120590 | 0.94 | HRH1 (0.72) | HRH1HTR1ADRD2ADRA2CHTR2A | |
| SCHEMBL18309819 | 0.93 | HRH1 (0.69) | HRH1HTR1ADRD2ADRA2CHTR2A | |
| Acetophenazine SCHEMBL29710923 | 0.89 | HRH1 (1.00) | HRH1HTR1ADRD2ADRA2CHTR2A | |
| Acetophenazine SCHEMBL94266 | 0.89 | HRH1 (1.00) | HRH1HTR1ADRD2ADRA2CHTR2A | |
| Fumaric Acid SCHEMBL26124087 | 0.86 | HRH1 (0.61) | HRH1HTR1ADRD2ADRA2CHTR2A | |
| Butaperazine SCHEMBL31153317 | 0.84 | HRH1 (0.67) | HRH1HTR1ADRD2ADRA2CHTR2A | |
| Butaperazine SCHEMBL29710903 | 0.84 | HRH1 (0.67) | HRH1HTR1ADRD2ADRA2CHTR2A | |
| Butaperazine SCHEMBL28086241 | 0.84 | HRH1 (0.67) | HRH1HTR1ADRD2ADRA2CHTR2A | |
| Butaperazine SCHEMBL119995 | 0.84 | HRH1 (0.67) | HRH1HTR1ADRD2ADRA2CHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2013 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106917-A1 | EDIBLE TRANSMUCOSAL DRUG DELIVERY METHOD USING AN INTERMEDIATE CAPSULE AS A TEMPORARY VESSEL | BioPhysics Pharma, Inc. (US) | 2026-05-21 | — | — | WO | claimed |
| US-12605345-B2 | Transdermal drug delivery system | BioPhysics Pharma, Inc. (US) | 2026-04-21 | — | — | US | claimed |
| EP-4618973-A1 | METHODS OF SWITCHING NEUROPSYCHIATRIC MEDICATIONS USING ULOTARONT | Sumitomo Pharma America, Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| US-20250268841-A1 | Trans-Epithelial Membrane Drug Delivery System | Masiz, John J. (US) | 2025-08-28 | — | — | US | claimed |
| US-20250120907-A1 | Transmucosal Drug Delivery System | Masiz, John J. (US) | 2025-04-17 | — | — | US | claimed |
| US-12246098-B2 | Trans-epithelial membrane drug delivery system | BioPhysics Pharma, Inc. (US) | 2025-03-11 | — | — | US | claimed |
| US-12178804-B2 | Salts of cycloserine compounds and applications thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2024-12-31 | — | — | US | claimed |
| US-12102640-B2 | Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration | UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) | 2024-10-01 | — | — | US | claimed |
| US-20240216292-A1 | Trans-Epithelial Membrane Drug Delivery System | Masiz, John J. (US) | 2024-07-04 | — | — | US | claimed |
| WO-2024107681-A1 | METHODS OF SWITCHING NEUROPSYCHIATRIC MEDICATIONS USING ULOTARONT | SUMITOMO PHARMA AMERICA, INC. (US) | 2024-05-23 | — | — | WO | claimed |
| EP-0174342-B1 | BRAIN-SPECIFIC ANALOGUES OF CENTRALLY ACTING AMINES | UNIVERSITY OF FLORIDA (US) | 1989-12-20 | — | — | EP | claimed |
| US-4690824-A | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range | REDI-ROWELL, INC. (US) | 1987-09-01 | — | — | US | claimed |
| EP-0222425-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-05-20 | — | — | EP | claimed |
| EP-0218300-A2 | Brain-specific drug delivery | UNIVERSITY OF FLORIDA (US) | 1987-04-15 | — | — | EP | claimed |
| EP-0174342-A1 | BRAIN-SPECIFIC ANALOGUES OF CENTRALLY ACTING AMINES. | UNIV FLORIDA (US) | 1986-03-19 | — | — | EP | claimed |
| WO-1985003937-A1 | BRAIN-SPECIFIC ANALOGUES OF CENTRALLY ACTING AMINES | UNIVERSITY OF FLORIDA (US) | 1985-09-12 | — | — | WO | claimed |
| EP-0110955-A1 | BRAIN-SPECIFIC DRUG DELIVERY. | UNIV FLORIDA (US) | 1984-06-20 | — | — | EP | claimed |
| WO-1983003968-A1 | BRAIN-SPECIFIC DRUG DELIVERY | UNIVERSITY OF FLORIDA (US) | 1983-11-24 | — | — | WO | claimed |
| US-4407800-A | TRYPANOCIDES | UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) | 1983-10-04 | — | — | US | claimed |
| US-4175119-A | Composition and method to prevent accidental and intentional overdosage with psychoactive drugs | PORTER GARRY L | 1979-11-20 | — | — | US | claimed |